We are live on ! Find out more
LPP

Long Path Partners Portfolio holdings

AUM $220M
1-Year Est. Return 25.96%
This Fund
S&P 500
This Quarter Est. Return
-5.36%
1 Year Est. Return
-25.96%
3 Year Est. Return
-4.33%
5 Year Est. Return
10 Year Est. Return
AUM
$292M
AUM Growth
+$15.8M
Cap. Flow
+$35.2M
Cap. Flow %
12.05%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
3
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
MLAB icon
Mesa Laboratories
MLAB
+$17.3M
2
ALKT icon
Alkami Technology
ALKT
+$12.6M
3
NCNO icon
nCino
NCNO
+$7.62M
4
IIIV icon
i3 Verticals
IIIV
+$1.51M

Top Sells

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$2.09M
2
DCBO
Docebo
DCBO
+$958K
3
IWM icon
iShares Russell 2000 ETF
IWM
+$517K
4
CPAY icon
Corpay
CPAY
+$238K

Sector Composition

Rank Sector Weight
1 Technology 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCNO icon
1
nCino
NCNO
$1.79B
$94M 32.15%
3,666,222
+300,221
+9% +$7.62M
ALKT icon
2
Alkami Technology
ALKT
$1.75B
$72.5M 24.78%
3,141,115
+572,292
+22% +$12.6M
CPAY icon
3
Corpay
CPAY
$23.5B
$40.7M 13.91%
135,144
-820
-0.6% -$238K
IIIV icon
4
i3 Verticals
IIIV
$379M
$27.5M 9.42%
1,093,418
+53,571
+5% +$1.51M
DCBO
5
Docebo
DCBO
$495M
$21.6M 7.4%
975,088
-40,100
-4% -$958K
PCOR icon
6
Procore
PCOR
$6.28B
$18.2M 6.24%
250,832
-28,315
-10% -$2.09M
MLAB icon
7
Mesa Laboratories
MLAB
$535M
$17.8M 6.1%
+227,223
New +$17.3M
IWM icon
8
iShares Russell 2000 ETF
IWM
$81.6B
-2,135
Closed -$517K

Similar funds

Long Path Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Long Path Partners held 8 positions worth $292M, up 5.7% from $277M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Long Path Partners deployed $35.2M of net new capital in Q4 2025, opening 1 new position and adding to 3 existing holdings. Its largest new stake was Mesa Laboratories: 227,223 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 100% of assets, up from 100% a quarter earlier.

On the sell side, the largest reduction was Procore, an estimated $2.09M trimmed.

  • Long Path Partners's largest Q4 2025 buy was Mesa Laboratories: 227,223 shares worth $17.8M.
  • Long Path Partners added most to Alkami Technology in Q4 2025, an estimated $12.6M increase.
  • Long Path Partners's biggest Q4 2025 reduction was Procore, cutting an estimated $2.09M.
  • Long Path Partners fully exited iShares Russell 2000 ETF in Q4 2025, selling an estimated $517K.
  • Long Path Partners's ten largest holdings make up 100% of its $292M portfolio in Q4 2025.
  • Long Path Partners opened 1 new position and closed 1 in Q4 2025.
  • Long Path Partners's portfolio value rose 5.7% quarter-over-quarter to $292M.

Based on Long Path Partners's 13F filing for Q4 2025, filed 17 Feb 2026.